RBC Capital Initiates Endo Health At Outperform

Analysts at RBC Capital initiated coverage on shares of Endo Health Solutions

with a Outperform rating. The target price for Endo Health Solutions is set to $80. Endo Health shares have jumped 52.31% over the past 52 weeks, while the S&P 500 index has surged 22.17% in the same period. Endo Health's shares dropped 0.48% to close at $63.71 on Friday.